Reduced statherin reactivity of human submandibular gland in diabetes

Oral Diseases

Volumn 17, Issue 2, 2011, Pages 217-220

  Isola, M ^a   Solinas, P ^a   Proto, E ^b   Cossu, M ^a   Lantini, M S ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b DEPARTMENT OF RADIOLOGY   (Italy)

Author keywords

Diabetes; Human; Immunogold; Statherin

Indexed keywords

GOLD; STATHERIN;

ADULT; ARTICLE; CALCIUM HOMEOSTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEHYDRATION; DEMINERALIZATION; DENTAL CARIES; DENTAL PELLICLE; DIABETES MELLITUS; HISTOCHEMISTRY; HUMAN; HUMAN CELL; MOUTH INFECTION; PRIORITY JOURNAL; PROTEIN SECRETION; SALIVARY GLAND; SALIVATION; SECRETORY GRANULE; STAINING; SUBMANDIBULAR GLAND; TOOTH DEVELOPMENT; TOOTH DISEASE;

ADULT; DIABETES MELLITUS, TYPE 2; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; SALIVARY PROTEINS AND PEPTIDES; SECRETORY VESICLES; SUBMANDIBULAR GLAND;

EID: 79951569437     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01725.x     Document Type: Article

References (28)

1. Aydin S (2007). A comparison of ghrelin, glucose, alpha-amylase and protein levels in saliva from diabetics. Biochem Mol Biol 40: 29-35.
2. Baumann H, Meyer P, Winter K, Lorenz G (1985). Sialochemical and morphology studies of the submandibular gland of the diabetic patient-a contribution to diabetic sialadenosis. Laryngol Rhinol Otol 64: 542-546.
3. Carda C, Carranza M, Arriaga A, Díaz A, Peydró A, Gomez de Ferraris ME (2005). Structural differences between alcoholic and diabetic parotid sialosis. Med Oral Pathol Oral Cir Bucal 10: 309-314.
4. Dodds MW, Yeh CK, Johnson DA (2000). Salivary alterations in type 2 (non-insulin-dependent) diabetes mellitus and hypertension. Community Dent Oral Epidemiol 28: 373-381.
5. Dodds MW, Johnson DA, Yeh CK (2005). Health benefits of saliva: a review. J Dent 33: 223-233.
6. Edgerton M, Koshlukova S, Araujo MWB, Patel RC, Dong J, Bruenn JA (2000). Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. Antimicrob Agents Chemother 44: 3310-3316.
7. García-Godoy F, Hicks MJ (2008). Maintaining the integrity of the enamel surface: the role of dental biofilm, saliva and preventive agents in enamel demineralization and remineralization. J Am Dent Assoc 139: 25-34.
8. Gibbons RJ, Hay DI (1988). Human salivary acidic proline-rich proteins and statherin promote the attachment of Actinomyces viscosus LY7 to apatitic surfaces. Infect Immun 56: 439-445.
9. Hirsch R (2004). Diabetes and periodontitis. Aust Prescr 27: 36-38.
10. Humphrey SP, Williamson RT (2001). A review of saliva: normal composition, flow and function. J Prost Dent 85: 162-168.
11. Isola M, Cabras T, Inzitari R et al (2008). Electron microscopic detection of statherin in secretory granules of human major salivary glands. J Anat 212: 664-668.
12. Javed F, Näsström K, Benchimol D, Altamash M, Klinge B, Engström PE (2007). Comparison of periodontal and socioeconomic status between subjects with type 2 diabetes mellitus and non-diabetic controls. J Periodontol 78: 2112-2119.
13. Kasayama S, Ohba Y, Oka T (1989). Epidermal growth factor deficiency associated with diabetes mellitus. Proc Natl Acad Sci USA 86: 7644-7648.
14. Kimura I, Sasamoto H, Sasamura T, Sugihara Y, Ohgaku S, Kobayashi M (2001). Reduction of incretin-like salivatin in saliva from patients with type 2 diabetes and in parotid glands of streptozotocin diabetic BALB/c mice. Diabetes Obes Metab 3: 254-258.
15. Lin BP, Taylor GW, Allen DJ, Ship JA (1999). Dental caries in older adults with diabetes mellitus. Spec Care Dentist 19: 8-14.
16. Mednieks MI, Szczepanski A, Clark B, Hand AR (2009). Protein expression in salivary glands of rats with streptozotocin diabetes. Int J Exp Pathol 90: 412-422.
17. Nieuw Amerongen AV, Veerman ECI (2002). Saliva - the defender of the oral cavity. Oral Dis 8: 12-22.
18. Patiño Marín N, Loyola Rodríguez JP, Medina Solis CE et al (2008). Caries, periodontal disease and tooth loss in patients with diabetes mellitus types 1 and 2. Acta Odontol Latinoam 21: 127-133.
19. Raj PA, Johnsson M, Levine MJ, Nancollas GH (1992). Salivary statherin. Dependence on sequence, charge, hydrogen bonding potency, and helical conformation for adsorption to hydroxyapatite and inhibition of mineralization. J Biol Chem 267: 5968-5976.
20. Rao PV, Reddy AP, Lu X et al (2009). Proteomic identification of salivary biomarkers of type-2 diabetes. J Proteome Res 8: 239-245.
21. Rudney JD, Staikov RK, Johnson JD (2009). Potential biomarkers of human salivary function: a modified proteomic approach. Arch Oral Biol 54: 91-100.
22. Sabino-Silva R, Freitas HS, Lamers ML, Okamoto MM, Santos MF, Machado UF (2009). Na+-Glucose cotransporter SGLT1 protein in salivary glands: potential involvement in the diabetes-induced decrease in salivary flow. Membr Biol 228: 63-69.
23. Schlesinger DH, Hay DI (1977). Complete covalent structure of statherin, a tyrosine-rich acidic peptide which inhibits calcium phosphate precipitation from human parotid saliva. J Biol Chem 252: 1689-1695.
24. Siudikiene J, Machiulskiene V, Nyvad B, Tenovuo J, Nedzelskiene I (2008). Dental caries increments and related factors in children with type 1 diabetes mellitus. Caries Res 42: 354-362.
25. Szczepanski A, Mednieks MI, Hand AR (1998). Expression and distribution of parotid secretory proteins in experimental diabetes. Eur J Morphol 36: 240-246.
26. Venza M, Visalli M, Cucinotta M, Cicciù D, Passi P, Teti D (2006). Salivary histamine level as a predictor of periodontal disease in type 2 diabetic and non-diabetic subjects. J Periodontol 77: 1564-1571.
27. Vitorino R, Lobo MJ, Duarte JR, Ferrer-Correia AJ, Domingues PM, Amado FM (2005). The role of salivary peptides in dental caries. Biomed Chromatogr 19: 214-222.
28. Yao Y, Berg EA, Costello CE, Troxler RF, Oppenheim FG (2003). Identification of protein components in human acquired enamel pellicle and whole saliva using novel proteomics approaches. J Biol Chem 278: 5300-5308.